[1]
2025. Effectiveness of bevacizumab biosimilars in the treatment of pulmonary diseases. Indian Journal of Biochemistry and Biophysics (IJBB). 63, 1 (Dec. 2025), 7–18. DOI:https://doi.org/10.56042/ijbb.v63i1.23922.